Profil
Serguei Nabirotchkine is the founder.
He founded Pharnext SA in 2007 and currently holds the title of Vice President & Head-Systems Biology.
Dr. Nabirotchkine also held the position of Director-Animal Model Department at Serono Genetics Institute SA.
Aktive Positionen von Serguei Nabirotchkine
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARNEXT SCA | Founder | 01.01.2007 |
Ehemalige bekannte Positionen von Serguei Nabirotchkine
| Unternehmen | Position | Ende |
|---|---|---|
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
